<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(6)</volume><submitter>Griffin TP</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Inactivating mutations in CYP24A1, encoding vitamin D-24-hydroxylase, can lead to an accumulation of active vitamin D metabolites and consequent hypercalcaemia. Patient (infantile and adult) presentation is varied and includes mild-severe hypercalcaemia, hypercalciuria, nephrocalcinosis and nephrolithiasis. This study aimed to characterize the clinical and biochemical phenotypes of a family with two CYP24A1 missense variants.&lt;h4>Methods&lt;/h4>The proband and seven family members underwent detailed clinical and biochemical evaluation. Laboratory measurements included serum calcium, intact parathyroid hormone (iPTH), vitamin D metabolites and urine calcium and creatinine.&lt;h4>Results&lt;/h4>The proband presented during the second trimester of a planned pregnancy with flu-like </pubmed_abstract><journal>Endocrine connections</journal><pagination>530-541</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7354719</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Biallelic CYP24A1 variants presenting during pregnancy: clinical and biochemical phenotypes.</pubmed_title><pmcid>PMC7354719</pmcid><pubmed_authors>Sayer JA</pubmed_authors><pubmed_authors>Islam MN</pubmed_authors><pubmed_authors>Gillan JE</pubmed_authors><pubmed_authors>Alkanderi S</pubmed_authors><pubmed_authors>O'Keeffe DT</pubmed_authors><pubmed_authors>Bogdanet D</pubmed_authors><pubmed_authors>Griffin TP</pubmed_authors><pubmed_authors>Morrison JJ</pubmed_authors><pubmed_authors>Bell M</pubmed_authors><pubmed_authors>O'Shea PM</pubmed_authors><pubmed_authors>Joyce CM</pubmed_authors><pubmed_authors>Blake LM</pubmed_authors><pubmed_authors>O'Brien T</pubmed_authors><pubmed_authors>Dennedy MC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Biallelic CYP24A1 variants presenting during pregnancy: clinical and biochemical phenotypes.</name><description>&lt;h4>Introduction&lt;/h4>Inactivating mutations in CYP24A1, encoding vitamin D-24-hydroxylase, can lead to an accumulation of active vitamin D metabolites and consequent hypercalcaemia. Patient (infantile and adult) presentation is varied and includes mild-severe hypercalcaemia, hypercalciuria, nephrocalcinosis and nephrolithiasis. This study aimed to characterize the clinical and biochemical phenotypes of a family with two CYP24A1 missense variants.&lt;h4>Methods&lt;/h4>The proband and seven family members underwent detailed clinical and biochemical evaluation. Laboratory measurements included serum calcium, intact parathyroid hormone (iPTH), vitamin D metabolites and urine calcium and creatinine.&lt;h4>Results&lt;/h4>The proband presented during the second trimester of a planned pregnancy with flu-like </description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jun</publication><modification>2025-04-19T11:40:04.976Z</modification><creation>2025-04-19T11:40:04.976Z</creation></dates><accession>S-EPMC7354719</accession><cross_references><pubmed>32375123</pubmed><doi>10.1530/EC-20-0150</doi></cross_references></HashMap>